Imaging of Hepatitis B Virus Nucleic Acids: Current Advances and Challenges
- PMID: 35336964
- PMCID: PMC8950347
- DOI: 10.3390/v14030557
Imaging of Hepatitis B Virus Nucleic Acids: Current Advances and Challenges
Abstract
Hepatitis B virus infections are the main reason for hepatocellular carcinoma development. Current treatment reduces the viral load but rarely leads to virus elimination. Despite its medical importance, little is known about infection dynamics on the cellular level not at least due to technical obstacles. Regardless of infections leading to extreme viral loads, which may reach 1010 virions per mL serum, hepatitis B viruses are of low abundance and productivity in individual cells. Imaging of the infections in cells is thus a particular challenge especially for cccDNA that exists only in a few copies. The review describes the significance of microscopical approaches on genome and transcript detection for understanding hepatitis B virus infections, implications for understanding treatment outcomes, and recent microscopical approaches, which have not been applied in HBV research.
Keywords: CRISPR/cas9; ClampFISH; MS2; OR protein; PP7; RNA transcripts; Sun-Tag; anchor; aptamer; branched chain DNA (bDNA); cccDNA; click chemistry; fluorescent in situ hybridization (FISH); hepatitis B virus; imaging; in situ hybridization (ISH); molecular beacon; peptide nucleic acids (PNA); quantum dots; sandwich nucleic acid hybridization; single cell analysis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach.World J Gastroenterol. 2021 Jun 21;27(23):3182-3207. doi: 10.3748/wjg.v27.i23.3182. World J Gastroenterol. 2021. PMID: 34163105 Free PMC article. Review.
-
Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.J Clin Virol. 2018 Feb-Mar;99-100:71-78. doi: 10.1016/j.jcv.2017.12.016. Epub 2018 Jan 6. J Clin Virol. 2018. PMID: 29353073
-
Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.J Hepatol. 2018 Dec;69(6):1231-1241. doi: 10.1016/j.jhep.2018.08.012. Epub 2018 Aug 22. J Hepatol. 2018. PMID: 30142426 Free PMC article.
-
Methylation profile of hepatitis B virus is not influenced by interferon α in human liver cancer cells.Mol Med Rep. 2021 Oct;24(4):715. doi: 10.3892/mmr.2021.12354. Epub 2021 Aug 13. Mol Med Rep. 2021. PMID: 34396432 Free PMC article.
-
Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure.J Hepatol. 2016 Apr;64(1 Suppl):S41-S48. doi: 10.1016/j.jhep.2016.02.009. J Hepatol. 2016. PMID: 27084036 Review.
Cited by
-
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure.Gut. 2023 May;72(5):972-983. doi: 10.1136/gutjnl-2022-328380. Epub 2023 Jan 27. Gut. 2023. PMID: 36707234 Free PMC article.
-
The premise of capsid assembly modulators towards eliminating HBV persistence.Expert Opin Drug Discov. 2023 Jul-Dec;18(9):1031-1041. doi: 10.1080/17460441.2023.2239701. Expert Opin Drug Discov. 2023. PMID: 37477111 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical